Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00351299
Status:
COMPLETED
Last Update Posted:
2017-06-09
First Post:
2006-07-10
Brief Title:
Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit ICU Delirium
Sponsor:
Brigham and Womens Hospital
Organization:
Brigham and Womens Hospital
Study Overview
Official Title:
Study of Dexmedetomidine as an Effective Sedative to Treat Acute ICU Delirium
Status:
COMPLETED
Status Verified Date:
2017-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the research is to see if dexmedetomidine a drug that has a calming effect - a sedative is effective for the treatment of acute delirium
Detailed Description:
Delirium is a mental disturbance that causes people to be confused and restless for a period of time We will compare dexmedetomidine to the traditional therapy for treatment of acute delirium Dexmedetomidine does not affect breathing The traditional drugs might make one sleepy and may slow down breathing The traditional therapy in this institution for acute delirium is _the use of Haloperidol andor benzodiazepines Haloperidol is an antipsychotic drug that has calming effect Benzodiazepines are sedatives with calming effectDexmedetomidine is approved by the Food and drug Administration FDA to sedate patients on a breathing machine for 24 hours
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None